Searchable abstracts of presentations at key conferences in endocrinology

ea0081p266 | Adrenal and Cardiovascular Endocrinology | ECE2022

WBC count. A potential tool for suspecting Cushing’s syndrome (CS)

Paja Fano Miguel , Merlo-Pascual Ignacio , Rodriguez-Soto Josune , Moure-Rodriguez M. Dolores , Monzon-Mendiolea Andoni , Egana-Zunzunegui Nerea , Elias-Ortega Cristina , Cruz-Iglesias Elena , Oleaga-Alday Amelia

Early diagnosis of CS could reduce the morbidity and mortality associated with endogenous hypercortisolism. Many clinical methods have been proposed to establish suspicion of CS, but they show a poor positive predictive value (PPV) and are sometimes difficult to assess. Assuming the well-known influence of hypercortisolism on white blood cell (WBC) count, we evaluated its potential usefulness as a screening test to trigger this suspicion. We analysed WBC count around the diagn...

ea0081ep1080 | Thyroid | ECE2022

Neutropenia in hyperthyroidism

Elias Ortega Cristina , Zunzunegui Nerea Egan a , Delgado Cristina Garcia , Calafell Maria Teresa Aramburu , Alvaro Jorge Rojo , Nebreda Inmaculada Venegas , Achucarro Ane Amilibia , Garay Ismene Bilbao , Arrieta Alfredo Yoldi

Introduction: Neutropenia can indicate infectious and hematological pathology but it can also be a sign of hyperthyroidism. For this reason, it has been suggested to perform a complete blood count before starting treatment with antithyroid drugs in case of new-onset hyperthyroidism. Antithyroid drugs can cause severe neutropenia, also called agranulocytosis, when the neutrophil count is less than 500/µl. Therefore, the use of these drugs should be reconsidered if it is le...

ea0073ep152 | Pituitary and Neuroendocrinology | ECE2021

Management of malignant insulina

Nerea Egaña Zunzunegui , Elias Ortega Cristina , Venegas Nebreda Inmaculada , Bilbao Garay Ismene , Aramburu Calafell Maite , Cristina García Delgado , Rojo Alvaro Jorge , Maite Perez de Ciriza Cordeu , Yoldi Arrieta Alfredo , Miguel Maria Goena Iglesias

IntroductionMalignant insulinoma is a rare pancreatic neuroendocrine tumor that accounts for only 10% of all cases of insulinoma. The clinical picture is characterized by the presence of severe hyperinsulinemic hypoglycaemic syndrome in a patient with pancreatic tumor with locoregional and/or distant metastases. Therapeutic management is challenging due to the need to control both hypoglycemic syndrome and tumor growth. Curative surgery is rarely applica...